MUC5AC and COVID-19: These results suggest that combinatory use of EH, SF, PR and GR decrease the level of NO and MUC5AC by regulating TNF-alpha signaling pathway, NF-κB signaling pathway, and calcium signaling pathway, thereby exert therapeutic effects on inflammation in post-COVID-19.